Biomnigene Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 1

Biomnigene General Information

Description

Developer of molecular biology and genetic sequencing technology designed to support scientific research and analysis. The company provides services such as blood cell extraction, Sanger and next-generation sequencing, microbiome analysis, and bioinformatics, enabling biotechnology companies and researchers to perform accurate genomic analysis and advance their projects.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 18 rue Alain Savary
  • 25000 Besancon
  • France
+33 03
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Discovery Tools (Healthcare)
Vertical(s)
Corporate Office
  • 18 rue Alain Savary
  • 25000 Besancon
  • France
+33 03

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biomnigene Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Generating Revenue
To view Biomnigene’s complete valuation and funding history, request access »

Biomnigene Patents

Biomnigene Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4496889-B1 Process for detecting the mutagenic character of chemical compounds Active 17-Mar-2023
EP-4496889-A1 Method for detecting the mutagenic character of chemical compounds Active 23-Mar-2022
WO-2023180209-A1 Method for detecting the mutagenic character of chemical compounds Inactive 23-Mar-2022
FR-3133860-B1 Method for detecting the mutagenic nature of chemical compounds Active 23-Mar-2022
FR-3133860-A1 Process for detecting the mutagenic nature of chemical compounds Active 23-Mar-2022 C12Q1/6827
To view Biomnigene’s complete patent history, request access »

Biomnigene Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biomnigene Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
TEMIS Technopole Accelerator/Incubator
To view Biomnigene’s complete investors history, request access »

Biomnigene FAQs

  • When was Biomnigene founded?

    Biomnigene was founded in 2018.

  • Where is Biomnigene headquartered?

    Biomnigene is headquartered in Besancon, France.

  • What is the size of Biomnigene?

    Biomnigene has 7 total employees.

  • What industry is Biomnigene in?

    Biomnigene’s primary industry is Biotechnology.

  • Is Biomnigene a private or public company?

    Biomnigene is a Private company.

  • What is Biomnigene’s current revenue?

    The current revenue for Biomnigene is .

  • Who are Biomnigene’s investors?

    TEMIS Technopole has invested in Biomnigene.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process